Annual EPS
N/A
31 December 2023
Summary:
AcelRx Pharmaceuticals annual earnings per share is not available.ACRX EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
N/A
31 December 2023
Summary:
AcelRx Pharmaceuticals quarterly earnings per share is not available.ACRX Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
N/A
31 December 2023
Summary:
AcelRx Pharmaceuticals TTM earnings per share is not available.ACRX TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRX EPS Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ACRX EPS High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time |
AcelRx Pharmaceuticals EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$0.08(-80.0%) | -$2.23(-27.8%) |
| June 2023 | - | -$0.40(-46.7%) | -$3.09(-152.5%) |
| Mar 2023 | - | -$0.75(-25.0%) | $5.89(+8.1%) |
| Dec 2022 | $5.72(-197.6%) | -$1.00(+6.4%) | $5.45(+3.8%) |
| Sept 2022 | - | -$0.94(-111.0%) | $5.25(+9.6%) |
| June 2022 | - | $8.58(-821.0%) | $4.79(-188.9%) |
| Mar 2022 | - | -$1.19(-0.8%) | -$5.39(-7.1%) |
| Dec 2021 | -$5.86(-37.7%) | -$1.20(-14.3%) | -$5.80(-12.1%) |
| Sept 2021 | - | -$1.40(-12.5%) | -$6.60(-8.3%) |
| June 2021 | - | -$1.60(0.0%) | -$7.20(0.0%) |
| Mar 2021 | - | -$1.60(-20.0%) | -$7.20(-25.0%) |
| Dec 2020 | -$9.40(-29.9%) | -$2.00(0.0%) | -$9.60(-14.3%) |
| Sept 2020 | - | -$2.00(+25.0%) | -$11.20(-9.7%) |
| June 2020 | - | -$1.60(-60.0%) | -$12.40(-11.4%) |
| Mar 2020 | - | -$4.00(+11.1%) | -$14.00(+4.5%) |
| Dec 2019 | -$13.40(-17.3%) | -$3.60(+12.5%) | -$13.40(0.0%) |
| Sept 2019 | - | -$3.20(0.0%) | -$13.40(-6.9%) |
| June 2019 | - | -$3.20(-5.9%) | -$14.40(-5.3%) |
| Mar 2019 | - | -$3.40(-5.6%) | -$15.20(-7.3%) |
| Dec 2018 | -$16.20(-26.4%) | -$3.60(-14.3%) | -$16.40(-1.2%) |
| Sept 2018 | - | -$4.20(+5.0%) | -$16.60(-7.8%) |
| June 2018 | - | -$4.00(-13.0%) | -$18.00(-9.1%) |
| Mar 2018 | - | -$4.60(+21.1%) | -$19.80(-10.0%) |
| Dec 2017 | -$22.00(+15.8%) | -$3.80(-32.1%) | -$22.00(-1.8%) |
| Sept 2017 | - | -$5.60(-3.4%) | -$22.40(+2.8%) |
| June 2017 | - | -$5.80(-14.7%) | -$21.80(+4.8%) |
| Mar 2017 | - | -$6.80(+61.9%) | -$20.80(+9.5%) |
| Dec 2016 | -$19.00 | -$4.20(-16.0%) | -$19.00(-3.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2016 | - | -$5.00(+4.2%) | -$19.60(+58.1%) |
| June 2016 | - | -$4.80(-4.0%) | -$12.40(+6.9%) |
| Mar 2016 | - | -$5.00(+4.2%) | -$11.60(-3.3%) |
| Dec 2015 | -$12.00(-34.1%) | -$4.80(-318.2%) | -$12.00(-11.8%) |
| Sept 2015 | - | $2.20(-155.0%) | -$13.60(-26.1%) |
| June 2015 | - | -$4.00(-25.9%) | -$18.40(-9.8%) |
| Mar 2015 | - | -$5.40(-15.6%) | -$20.40(+5.2%) |
| Dec 2014 | -$18.20(+54.2%) | -$6.40(+146.2%) | -$19.40(+304.2%) |
| Sept 2014 | - | -$2.60(-56.7%) | -$4.80(-35.1%) |
| June 2014 | - | -$6.00(+36.4%) | -$7.40(-31.5%) |
| Mar 2014 | - | -$4.40(-153.7%) | -$10.80(-18.2%) |
| Dec 2013 | -$11.80(-60.9%) | $8.20(-257.7%) | -$13.20(-55.7%) |
| Sept 2013 | - | -$5.20(-44.7%) | -$29.80(-7.5%) |
| June 2013 | - | -$9.40(+38.2%) | -$32.20(+8.1%) |
| Mar 2013 | - | -$6.80(-19.0%) | -$29.80(-1.3%) |
| Dec 2012 | -$30.20(+30.2%) | -$8.40(+10.5%) | -$30.20(+6.3%) |
| Sept 2012 | - | -$7.60(+8.6%) | -$28.40(+6.0%) |
| June 2012 | - | -$7.00(-2.8%) | -$26.80(+8.1%) |
| Mar 2012 | - | -$7.20(+9.1%) | -$24.80(+5.1%) |
| Dec 2011 | -$23.20(+56.7%) | -$6.60(+10.0%) | -$23.60(+14.4%) |
| Sept 2011 | - | -$6.00(+20.0%) | -$20.64(-83.1%) |
| June 2011 | - | -$5.00(-16.7%) | -$122.24(-45.8%) |
| Mar 2011 | - | -$6.00(+65.0%) | -$225.44(-33.0%) |
| Dec 2010 | -$14.81(-97.9%) | -$3.64(-96.6%) | -$336.44(-24.5%) |
| Sept 2010 | - | -$107.60(-0.6%) | -$445.40(+31.9%) |
| June 2010 | - | -$108.20(-7.5%) | -$337.80(+47.1%) |
| Mar 2010 | - | -$117.00(+3.9%) | -$229.60(+103.9%) |
| Dec 2009 | -$698.60(+11.0%) | -$112.60 | -$112.60 |
| Dec 2008 | -$629.33 | - | - |
FAQ
- What is the all time high annual EPS for AcelRx Pharmaceuticals?
- What is the all time high quarterly EPS for AcelRx Pharmaceuticals?
- What is the all time high TTM EPS for AcelRx Pharmaceuticals?
What is the all time high annual EPS for AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals all-time high annual earnings per share is $5.72
What is the all time high quarterly EPS for AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals all-time high quarterly earnings per share is $8.58
What is the all time high TTM EPS for AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals all-time high TTM earnings per share is $5.89